Medicines in Development for Cancer 2020 Report

A teaser image of the 2020 PhRMA Medicines in Development for Cancer Report

In the last 30 years, significant progress has been made in the fight against cancer. To continue the progress and deliver hope to those battling cancer, biopharmaceutical research companies are working to develop more effective and better tolerated treatments. Today, more than 1,300 medicines and vaccines for various cancers are currently in development by innovative biopharmaceutical research companies, all of which are in clinical trials or awaiting review by the U.S. Food and Drug Administration (FDA).

Interested in reading more about Medicines in Development for Cancer in 2020?

Get your free copy of the report now.